Metabolic syndrome (MetS) is a cluster of cardiometabolic risk factors with high prevalence
among adult populations and elevated costs for public health systems worldwide. Despite …

Small, dense low density lipoprotein (sdLDL) represents an emerging cardiovascular risk
factor, since these particles can be associated with cardiovascular disease (CVD) …

Objective—To investigate the relationship between plasma levels of small dense low-
density lipoprotein-cholesterol (sdLDL-C) and risk for incident coronary heart disease (CHD) …

Abstract Significance: Metabolic syndrome (MetS) is associated with a greater risk of
diabetes and cardiovascular diseases. It is estimated that this multifactorial condition affects …

Fat accumulation in the pancreas associated with obesity and the metabolic syndrome
(MetS) has been defined as “non-alcoholic fatty pancreas disease”(NAFPD). The aim of this …

Although results from in vitro studies and clinical trials demonstrate strong associations
between oxidative stress and cardiovascular risk, to date still no convincing data are …

Hypertension, a prevalent risk factor for cardiovascular disease, frequently occurs in
conjunction with metabolic disturbances and in particular with dyslipidaemia; such …

Metabolic syndrome (MetS) comprises interrelated disease states including obesity, insulin
resistance and type 2 diabetes (T2DM), dyslipidemia, and hypertension. Essential to normal …

Obesity is a pathological condition aggregating a substantial number of proatherogenic
factors, such as insulin resistance, type 2 diabetes mellitus, dyslipidaemia and hypertension …

Objective Small, dense low‐density lipoproteins (LDL) are a feature of the metabolic
syndrome (MS) but their predictive role still remains to be established. We performed a 2 …